5-Bromo-2'-deoxyuridine (Compound)

Synonyms:5-BROMO-2'-DEOXYURIDINE, 59-14-3, Broxuridine, Bromodeoxyuridine, 5-Bromodeoxyuridine, 5-BrdU, BRDU, BUDR, 5-Bromouracil deoxyriboside, Bromouracil deoxyriboside, 5-Bromodesoxyuridine, 5-Bdu, Broxuridinum, 5-Bromo-2-deoxyuridine, Broxuridina, 5-Bromouracil-2-deoxyriboside, C9H11BrN2O5, NSC-38297, Uridine, 5-bromo-2'-deoxy-, CHEBI:472552, CHEMBL222280, 5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, DTXSID7033105, 5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil, G34N38R2N1, 5-Bromo-2'-deoxyuridine (BRDU), NCGC00090770-05, MFCD00006529, 5-Bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione, Broxuridine [INN], DTXCID5013105, Broxuridinum [INN-Latin], BDU, Broxuridina [INN-Spanish], CAS-59-14-3, SMR001227189, bromodeoxyuridine (brdu), CCRIS 818, HSDB 7477, Broxuridine [INN:JAN], EINECS 200-415-9, (+)-5-Bromo-2'-deoxyuridine, BRN 0030395, UNII-G34N38R2N1, 5-Bromo-2'-deoxyuridine(BRDU), 5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione, 5-Bromo-dURD, 5-brom-2'-desoxyuridin, Broxuridine (JAN/INN), BROXURIDINE [MI], Maybridge4_003385, BROXURIDINE [JAN], BROXURIDINE [HSDB], Epitope ID:138105, 5-bromo-2'-deoxy uridine, cid_6035, BROXURIDINE [MART.], Lopac0_000212, SCHEMBL27755, BROXURIDINE [WHO-DD], 4-24-00-01234 (Beilstein Handbook Reference), MLS001055406, MLS002153366, 5-Bromo-2'-deoxyuridine, 97%, HMS1619B05, HMS3039G15, HMS3260L05, BCP21681, 5-BROMO-2''-DEOXY URIDINE, Tox21_111016, Tox21_200106, Tox21_500212, BDBM50207303, HB0979, HG1160, STL530083, AKOS001715166, AKOS016015753, AKOS037495737, Tox21_111016_1, CCG-204307, DB12028, LP00212, SDCCGSBI-0050200.P002, BrdU (5-Bromo-2′-deoxyuridine), NCGC00090770-01, NCGC00090770-02, NCGC00090770-03, NCGC00090770-04, NCGC00090770-06, NCGC00090770-07, NCGC00090770-08, NCGC00090770-09, NCGC00090770-14, NCGC00175901-01, NCGC00257660-01, NCGC00260897-01, 1-[(4S,2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-bromo-1,3-dihydropyrim idine-2,4-dione, 5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione, AS-11762, BP-58665, HY-15910, 5-Bromo-2'-deoxyuridine, >=99% (HPLC), B1575, EU-0100212, 5-Bromo-2'-deoxyuridine, BioUltra, >=99%, 5-Bromo-2'-deoxyuridine, >=99.0% (HPLC), B 5002, D01763, 5- Br-2 inverted exclamation mark -deoxyuridine, EN300-7376709, Q419861, SR-01000075718, J-700086, SR-01000075718-1, Br-dU; 5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil, Carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoromethylketone, (+)-5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]- pyrimidine-2,4-dione, 5-bromo-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-4-hydroxypyrimidin-2(1H)-one, 5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyridine-2,4(1H,3H)-dione, 5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
Id:6035
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 5-Bromo-2'-deoxyuridine's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for 5-Bromo-2'-deoxyuridine.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with 5-Bromo-2'-deoxyuridine.

Results found

Linked to

 

Label

Description

 

Substance

A Substance

Collection

DrugPage Collection: (DrugCentralID:03042; PubChem_CID:6035, FILE=drugcentral_drug_03042.json)

Collection

Metadatata for broxuridine


  • Collection

    DrugPage Collection: (DrugCentralID:03042; PubChem_CID:6035, FILE=drugcentral_drug_03042.json)


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.